FindTrial
Sign In

Phacoemusification combined with intravitreal injection of Conbercept in the treatment of diabetic macular edema with coexisting cataract

Phacoemusification combined with intravitreal injection of Conbercept in the treatment of diabetic macular edema with coexisting cataract

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017241
Enrollment
Unknown
Registered
2018-07-19
Start date
2018-03-18
Completion date
Unknown
Last updated
2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic macular edema

Interventions

Case series:operation

Sponsors

Tianjin Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with coexisting visually significant cataract and diabetic macular edema

Exclusion criteria

Exclusion criteria: proliferative diabetic retinopathy, glaucoma, pathological myopia, and other eye diseases may affect corrected vision. This study also excludes the patients which are not satisfied with glycemic and blood pressure control.

Design outcomes

Primary

MeasureTime frame
Best-corrected visual;—

Countries

China

Contacts

Public ContactYue Zhang

Tianjin Eye Hospital

zmoon0225@126.com15602061989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026